RK Pharma`s Generic Cyclophosphamide Receives Approval in the U.S.
PEARL RIVER, N.Y.--(BUSINESS WIRE)--RK Pharma Inc, a vertically integrated pharmaceutical company today announced the successful completion of the acquisition of VGYAAN Pharmaceuticals LLC.
RK Pharma Inc, a vertically integrated pharmaceutical company, will receive an investment of $200 million from PAG, a global investment firm.
PEARL RIVER, N.Y.--(BUSINESS WIRE)--RK Pharma Inc, a vertically integrated pharmaceutical company based in the U.S. with subsidiaries in India, announced today an investment of up to 200 million USD from PAG, a leading global investment firm. Terms of the deal were not disclosed.
RK Pharma Receives Generic Safinamide Mesylate Tentative Approval in the U.S.A